首页> 外国专利> USE OF 5-{2-HYDROXY-3-1-(3-TRIFLUOROMETHYLPHENYL) CYCLOPROPYLPROPYONYLAMINO}PHTALIDE AND RELATIVE COMPOUNDS POSSESSING MODULATING ACTIVITY RELATIVE TO PROGESTERONE RECEPTOR FOR CONTRACEPTION AND HORMONE REPLACEMENT THERAPY

USE OF 5-{2-HYDROXY-3-1-(3-TRIFLUOROMETHYLPHENYL) CYCLOPROPYLPROPYONYLAMINO}PHTALIDE AND RELATIVE COMPOUNDS POSSESSING MODULATING ACTIVITY RELATIVE TO PROGESTERONE RECEPTOR FOR CONTRACEPTION AND HORMONE REPLACEMENT THERAPY

机译:5- {2-羟基-3- [1-(3-三氟甲苯基)环丙基]丙交酯} PH和相对化合物的赋形剂相对于孕激素受体的调节活性,用于避孕和激素替代治疗

摘要

The present invention relates to non-steroidal progestins of the general formula (I) wherein R1 and R2 are independently of each other -H or -F, R3 is -CH3 or -CF3, and Ar is (a) or (b), or a pharmaceutically acceptable derivative or analogue thereof. These progestins are suitable for selectively modulating progesterone receptor mediated effects in different target tissues, particularly in uterine tissue versus breast tissue. Therefore, the progestins of the present invention, optionally in combination with estrogens, may be used for contraception (in particular in estrogen-free oral contraceptives), hormone replacement therapy and the treatment of gynecological disorders. The present invention furthermore relates to methods for selectively modulating progesterone receptor mediated effects in different target tissues or organs. (I) or (a)(b)
机译:本发明涉及通式(I)的非甾体孕激素,其中R 1和R 2彼此独立地为-H或-F,R 3为-CH 3或-CF 3,并且Ar为(a)或(b),或其药学上可接受的衍生物或类似物。这些孕激素适合于在不同的靶组织中,特别是在子宫组织与乳房组织中,选择性地调节孕酮受体介导的作用。因此,本发明的孕激素,任选地与雌激素组合,可以用于避孕(特别是在无雌激素的口服避孕药中),激素替代疗法和妇科疾病的治疗。本发明还涉及在不同靶组织或器官中选择性调节孕酮受体介导的作用的方法。 (I)或(a)(b)

著录项

  • 公开/公告号UA78027C2

    专利类型

  • 公开/公告日2007-02-15

    原文格式PDF

  • 申请/专利权人 SCHERING AG;

    申请/专利号UA20041008153

  • 发明设计人

    申请日2003-03-10

  • 分类号A61K;A61K;A61K;A61K;A61K;A61P;A61P;A61P;A61P;C07D;C07D;

  • 国家 UA

  • 入库时间 2022-08-21 20:56:06

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号